Vectormune FP ILT

Nazione: Unione Europea

Lingua: estone

Fonte: EMA (European Medicines Agency)

Principio attivo:

recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live

Commercializzato da:

CEVA-Phylaxia Co. Ltd.

INN (Nome Internazionale):

Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)

Gruppo terapeutico:

Kana

Indicazioni terapeutiche:

For active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Stato dell'autorizzazione:

Volitatud

Data dell'autorizzazione:

2020-12-09

Foglio illustrativo

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.

Scheda tecnica

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Selle veterinaarravimi ajakohane teave on veterinaarravimite teabe
veebilehel.